Millennium Pharmaceuticals, Inc.
takeda.comTotal trials
178
Active
0
Phase 3
19
Total enrollment
20,283
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Multiple Myeloma24
- Advanced Solid Tumors14
- Healthy Volunteers11
- Prostate Cancer11
- Lymphoma8
- Acute Myelogenous Leukemia6
- Advanced Nonhematologic Malignancies5
- Prostatic Neoplasms4
Frequently asked questions about Millennium Pharmaceuticals, Inc.
- How many clinical trials does Millennium Pharmaceuticals, Inc. have on ClinicalTrials.gov?
- Millennium Pharmaceuticals, Inc. is listed as the lead sponsor on 178 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Millennium Pharmaceuticals, Inc.'s trials are in Phase 3?
- 19 of Millennium Pharmaceuticals, Inc.'s trials are in Phase 3.
- What therapeutic areas does Millennium Pharmaceuticals, Inc. focus on?
- Millennium Pharmaceuticals, Inc.'s most-studied conditions on ClinicalTrials.gov are Multiple Myeloma, Advanced Solid Tumors, Healthy Volunteers, Prostate Cancer, Lymphoma.